NCT02803450

Brief Summary

This prospective, randomized, single blinded control trial will investigate the effects of epidural loading with a high volume, low concentration local anesthetic solution via the epidural needle versus the epidural catheter.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2016

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 14, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 17, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

September 27, 2021

Status Verified

September 1, 2021

Enrollment Period

11 months

First QC Date

June 14, 2016

Last Update Submit

September 21, 2021

Conditions

Keywords

Effects of; Anesthesiaspinal and epidural

Outcome Measures

Primary Outcomes (2)

  • Patient Pain Levels (VAS Assessment)

    Patients will be assessed for pain levels on the VAS scale after analgesia administration in both arms

    During Labor

  • Patient Satisfaction

    Patient satisfaction with analgesia using a Likert rating of patient satisfaction with anesthetic care.

    During labor

Secondary Outcomes (5)

  • Analgesic level

    20 minutes

  • Maternal Vital Signs

    20 minutes

  • Fetal Heart Rate

    20 minutes

  • Rescue Bolus

    During Labor

  • Intravascular Catheter Placement

    During labor

Study Arms (3)

High Volume, Low Concentration via Epidural Needle

EXPERIMENTAL

Epidural loading: Participants will receive 20ml of 0.0625% bupivacaine with fentanyl 1mcg/ml epidural loading dose in 10ml increments five minutes apart via epidural needle followed by catheter placement. For continuous infusions: The continuous patient controlled epidural anesthesia (PCEA) pump will contain 0.03125% bupivacaine with 1mcg/ml fentanyl. The infusion rate will be set at 20ml/hr basal rate and 8ml every 15 minutes on demand with lockout of 52ml/hr. For inadequate analgesia: One additional 10ml boluses of the experimental 0.0625% bupivacaine with 1mcg/ml will be provided spaced 5 minutes apart via the epidural catheter.

Procedure: Epidural needle

High Volume, Low Concentration via Epidural Catheter

EXPERIMENTAL

Epidural loading: Participants will receive 20ml of 0.0625% bupivacaine with fentanyl 1mcg/ml epidural loading dose in 10ml increments five minutes apart via the epidural catheter administration following catheter placement. For continuous infusions: The continuous patient controlled epidural anesthesia (PCEA) pump will contain 0.03125% bupivacaine with 1mcg/ml fentanyl. The infusion rate will be set at 20ml/hr basal rate and 8ml every 15 minutes on demand with lockout of 52ml/hr. For inadequate analgesia: One additional 10ml boluses of the experimental 0.0625% bupivacaine with 1mcg/ml will be provided spaced 5 minutes apart via the epidural catheter.

Procedure: Catheter Administration

Low Volume, High Concentration via Epidural Catheter

ACTIVE COMPARATOR

Standard of Care Epidural Administration Epidural loading: Participants will receive 10ml of 0.125% bupivacaine with fentanyl 2mcg/ml in 5 ml increments 5 minutes apart via the epidural catheter following epidural catheter placement, per standard of care. For continuous infusions: The continuous patient controlled epidural anesthesia (PCEA) pump will contain 0.0625% bupivacaine with 2mcg/ml fentanyl. The infusion rate will be set at 10ml/hr basal rate and 4ml every 15 minutes on demand with lockout of 26ml/hr. For inadequate analgesia: One additional 5ml boluses of the standard 0.125% bupivacaine with 2mcg/ml will be provided spaced 5 minutes apart via the epidural catheter.

Procedure: Standard of Care Epidural Administration

Interventions

Medication administration via epidural needle.

High Volume, Low Concentration via Epidural Needle

Medication administration via epidural catheter.

High Volume, Low Concentration via Epidural Catheter

Medication administered at higher concentration, lower volume via epidural catheter.

Also known as: Epidural catheter
Low Volume, High Concentration via Epidural Catheter

Eligibility Criteria

Age18 Years - 89 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects who have volunteered and consented to participation in the study upon admission to labor and delivery
  • Parturients in active labor requesting epidural analgesia
  • Uncomplicated pregnancy with a reassuring fetal heart tracing
  • Age greater than or equal to 18 years

You may not qualify if:

  • Contraindication to epidural anesthesia
  • Inability to read, comprehend, and sign the informed consent form
  • Fetal intrauterine growth retardation (IUGR)
  • Non-reassuring fetal heart tracing
  • Cervical dilation greater than 7cm
  • Intra-uterine fetal demise
  • History of chronic pain other than in the back
  • Incarcerated patients I. Any patient enrolled in the study in whom there is evidence of dural puncture during epidural technique (\>3 attempts, presence of CSF)
  • j. Any evidence of high spinal after initial bolus or continuous infusion of high volume, low concentration local anesthetic solution k. Women undergoing cesarean section

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

Location

Study Officials

  • Goran Ristev, MD

    The Ohio State Univeristy

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Clinical Professor of Anesthesiology

Study Record Dates

First Submitted

June 14, 2016

First Posted

June 17, 2016

Study Start

February 1, 2016

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

September 27, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations